de Boer NKH - Search Results

1

Tofacitinib for ulcerative colitis: results of the prospective Dutch Initiative on Crohn and Colitis (ICC) registry.

Biemans VBC, Sleutjes JAM, de Vries AC, Bodelier AGL, Dijkstra G, Oldenburg B, Löwenberg M, van Bodegraven AA, van der Meulen-de Jong AE, de Boer NKH, Srivastava N, West RL, Römkens TEH, Horjus Talabur Horje CS, Jansen JM, van der Woude CJ, Hoekstra J, Weersma RK, van Schaik FDM, Hoentjen F, Pierik MJ; Dutch Initiative on Crohn and Colitis (ICC). Biemans VBC, et al. Among authors: de boer nkh, de vries ac. Aliment Pharmacol Ther. 2020 May;51(9):880-888. doi: 10.1111/apt.15689. Epub 2020 Apr 1. Aliment Pharmacol Ther. 2020. PMID: 32237087 Free PMC article.

2

Microscopic colitis.

Mulder CJ, Harkema IM, Meijer JW, De Boer NK. Mulder CJ, et al. Rom J Gastroenterol. 2004 Jun;13(2):113-7. Rom J Gastroenterol. 2004. PMID: 15229775 Review.

3

On the limitation of 6-tioguaninenucleotide monitoring during tioguanine treatment.

de Boer NK, de Graaf P, Wilhelm AJ, Mulder CJ, van Bodegraven AA. de Boer NK, et al. Aliment Pharmacol Ther. 2005 Sep 1;22(5):447-51. doi: 10.1111/j.1365-2036.2005.02581.x. Aliment Pharmacol Ther. 2005. PMID: 16128683

4

Nodular regenerative hyperplasia and thiopurines: the case for level-dependent toxicity.

de Boer NK, Mulder CJ, van Bodegraven AA. de Boer NK, et al. Liver Transpl. 2005 Oct;11(10):1300-1. doi: 10.1002/lt.20554. Liver Transpl. 2005. PMID: 16184561 Free article. No abstract available.

5

On tolerability and safety of a maintenance treatment with 6-thioguanine in azathioprine or 6-mercaptopurine intolerant IBD patients.

de Boer NK, Derijks LJ, Gilissen LP, Hommes DW, Engels LG, de-Boer SY, den Hartog G, Hooymans PM, Mäkelburg AB, Westerveld BD, Naber AH, Mulder CJ, de Jong DJ. de Boer NK, et al. World J Gastroenterol. 2005 Sep 21;11(35):5540-4. doi: 10.3748/wjg.v11.i35.5540. World J Gastroenterol. 2005. PMID: 16222751 Free PMC article.

6

6-Thioguanine for Crohn's disease during pregnancy: thiopurine metabolite measurements in both mother and child.

de Boer NK, Van Elburg RM, Wilhelm AJ, Remmink AJ, Van Vugt JM, Mulder CJ, Van Bodegraven AA. de Boer NK, et al. Scand J Gastroenterol. 2005 Nov;40(11):1374-7. doi: 10.1080/00365520510024089. Scand J Gastroenterol. 2005. PMID: 16334449

7

Myelotoxicity and hepatotoxicity during azathioprine therapy.

de Boer NK, Mulder CJ, van Bodegraven AA. de Boer NK, et al. Neth J Med. 2005 Dec;63(11):444-6. Neth J Med. 2005. PMID: 16397313 Free article.

8

Impracticalities of thiopurine S-methyltransferase determination in daily inflammatory bowel disease practice.

de Boer NK, Mulder CJ, van Bodegraven AA. de Boer NK, et al. Aliment Pharmacol Ther. 2006 Apr 15;23(8):1278-9; author reply 1279-80. doi: 10.1111/j.1365-2036.2006.02831.x. Aliment Pharmacol Ther. 2006. PMID: 16611294 No abstract available.

9

Azathioprine use during pregnancy: unexpected intrauterine exposure to metabolites.

de Boer NK, Jarbandhan SV, de Graaf P, Mulder CJ, van Elburg RM, van Bodegraven AA. de Boer NK, et al. Am J Gastroenterol. 2006 Jun;101(6):1390-2. doi: 10.1111/j.1572-0241.2006.00538.x. Am J Gastroenterol. 2006. PMID: 16771965

10

Extended thiopurine metabolite assessment during 6-thioguanine therapy for immunomodulation in Crohn's disease.

de Boer NK, Derijks LJ, Keizer-Garritsen JJ, Lambooy LH, Ruitenbeek W, Hooymans PM, van Bodegraven AA, de Jong DJ. de Boer NK, et al. J Clin Pharmacol. 2007 Feb;47(2):187-91. doi: 10.1177/0091270006294403. J Clin Pharmacol. 2007. PMID: 17244769 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

303 results

Search Page

Filters